<SEC-DOCUMENT>0001193125-25-053947.txt : 20250313
<SEC-HEADER>0001193125-25-053947.hdr.sgml : 20250313
<ACCEPTANCE-DATETIME>20250313162541
ACCESSION NUMBER:		0001193125-25-053947
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250312
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250313
DATE AS OF CHANGE:		20250313

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Equitable Holdings, Inc.
		CENTRAL INDEX KEY:			0001333986
		STANDARD INDUSTRIAL CLASSIFICATION:	INSURANCE AGENTS BROKERS & SERVICES [6411]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				585512450
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38469
		FILM NUMBER:		25736174

	BUSINESS ADDRESS:	
		STREET 1:		1345 AVENUE OF THE AMERICAS
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10105
		BUSINESS PHONE:		(212) 554-1234

	MAIL ADDRESS:	
		STREET 1:		1345 AVENUE OF THE AMERICAS
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AXA Equitable Holdings, Inc.
		DATE OF NAME CHANGE:	20171107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AXA AMERICA HOLDINGS, INC.
		DATE OF NAME CHANGE:	20050722
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d937167d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:axaeq="http://www.axa-equitable.com/20250312" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-271">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-03-12_to_2025-03-12">0001333986</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="axaeq-20250312.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-03-12_to_2025-03-12"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001333986</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-03-12</xbrli:startDate> <xbrli:endDate>2025-03-12</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001333986</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-03-12</xbrli:startDate> <xbrli:endDate>2025-03-12</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001333986</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-03-12</xbrli:startDate> <xbrli:endDate>2025-03-12</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesCPreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001333986</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-03-12</xbrli:startDate> <xbrli:endDate>2025-03-12</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-306">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-03-12_to_2025-03-12" format="ixt:datemonthdayyearen" id="ixv-307">March 12, 2025</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img src="g937167g0313090520478.jpg" alt="LOGO"/></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-308">Equitable Holdings, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-03-12_to_2025-03-12" format="ixt-sec:stateprovnameen" id="ixv-309">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-310">001-38469</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-311">90-0226248</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction of</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">incorporation or organization)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-312">1345 Avenue of the Americas</ix:nonNumeric>,</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-313">New York</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-03-12_to_2025-03-12" format="ixt-sec:stateprovnameen" id="ixv-314">New York</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-315">10105</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Zip Code)</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-316">(212)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-317">554-1234</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or address, if changed since last report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-03-12_to_2025-03-12" format="ixt-sec:boolballotbox" id="ixv-318">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-03-12_to_2025-03-12" format="ixt-sec:boolballotbox" id="ixv-319">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-03-12_to_2025-03-12" format="ixt-sec:boolballotbox" id="ixv-320">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-03-12_to_2025-03-12" format="ixt-sec:boolballotbox" id="ixv-321">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:1pt; font-family:Times New Roman"><span style="font-family:Times New Roman; font-size:1pt;color:#ffffff">Securities registered pursuant to Section&#160;12(b) of the Act:</span><span style="font-family:Times New Roman"></span></p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of Exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" id="ixv-322">Common Stock</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" id="ixv-323">EQH</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen" id="ixv-324">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" id="ixv-325">Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series A</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" id="ixv-326">EQH PR A</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" format="ixt-sec:exchnameen" id="ixv-327">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesCPreferredStockMember" id="ixv-328">Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series C</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesCPreferredStockMember" id="ixv-329">EQH PR C</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesCPreferredStockMember" format="ixt-sec:exchnameen" id="ixv-330">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act (17 CFR 230.405) or Rule 12b-2 under the Exchange Act (17 CFR 240.12b-2).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-03-12_to_2025-03-12" format="ixt-sec:boolballotbox" id="ixv-331">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Information. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;12, 2025, Equitable Holdings, Inc. entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Citigroup Global Markets Inc., Morgan Stanley&#160;&amp; Co. LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC for the sale of $500&#160;million aggregate principal amount of Equitable Holdings, Inc.&#8217;s 6.700% <span style="white-space:nowrap"><span style="white-space:nowrap">fixed-to-fixed</span></span> reset rate junior subordinated debt securities due 2055 (the &#8220;junior subordinated debt securities&#8221;). The junior subordinated debt securities have been registered under the Securities Act of 1933, as amended, pursuant to Equitable Holdings, Inc.&#8217;s registration statement on Form <span style="white-space:nowrap">S-3</span> (Registration <span style="white-space:nowrap">No.&#160;333-282204)</span> filed with the Securities and Exchange Commission on October&#160;4, 2024. The Underwriting Agreement contains customary representations, warranties and covenants by Equitable Holdings, Inc., indemnification and contribution obligations and other customary terms and conditions. On March&#160;26, 2025, subject to the closing conditions set forth in the Underwriting Agreement, Equitable Holdings, Inc. expects to complete the issuance and sale of the junior subordinated debt securities and receive net proceeds, after expenses and the underwriting discount, of approximately $494&#160;million. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Underwriting Agreement described above does not purport to be complete and is qualified in its entirety by reference to the full text of such document, a copy of which is filed as Exhibit 1.1 hereto and is incorporated by reference herein. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Description of Exhibit</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d937167dex11.htm">Underwriting Agreement, dated as of March&#160;12, 2025, among Equitable Holdings, Inc. and Citigroup Global Markets Inc., Morgan Stanley&#160;&amp; Co. LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">EQUITABLE HOLDINGS, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: March&#160;13, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ralph Petruzzo</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Ralph Petruzzo</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Deputy General Counsel</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d937167dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXECUTION VERSION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Equitable
Holdings, Inc. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$500,000,000 6.700% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Fixed</FONT></FONT>
Reset Rate Junior Subordinated Debt </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Securities due 2055 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNDERWRITING AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">March&nbsp;12, 2025 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:56%; font-size:10pt; font-family:Times New Roman" ALIGN="center">March&nbsp;12, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">388 Greenwich Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10013 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1585 Broadway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10036 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Truist Securities, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3333 Peachtree Road NE, 11<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Atlanta, Georgia 30326 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">550 South Tryon Street, 5th Floor
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Charlotte, NC 28202 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Equitable Holdings, Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;), proposes to issue and sell to Citigroup Global Markets Inc.,
Morgan Stanley&nbsp;&amp; Co. LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC (the &#147;<B>Underwriters</B>&#148;) $500,000,000 principal amount of its 6.700%
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Fixed</FONT></FONT> Reset Rate Junior Subordinated Debt Securities due 2055 (the &#147;<B>Securities</B>&#148;). The Securities will be issued pursuant to the Junior
Subordinated Indenture, dated as of September&nbsp;18, 2024, as supplemented by the First Supplemental Indenture (together, the &#147;<B>Indenture</B>&#148;), to be dated as of March 26, 2025, between the Company and The Bank of New York Mellon, as
trustee (the &#147;<B>Trustee</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has filed with the Securities and Exchange Commission (the
&#147;<B>Commission</B>&#148;) a shelf registration statement under the Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;), on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File
<FONT STYLE="white-space:nowrap">No.&nbsp;333-282204),</FONT> including a prospectus, relating to the Securities. The registration statement as amended to the date of this Agreement, including the information (if any) deemed to be part of the
registration statement pursuant to Rule&nbsp;430B under the Securities Act, is hereinafter referred to as the &#147;<B>Registration Statement</B>&#148;; the related prospectus covering the Securities that was included in the Registration Statement
when it became effective on October&nbsp;4, 2024 in the form first used to confirm sales of the Securities (or in the form first made available to the Underwriters by the Company to meet requests of purchasers pursuant to Rule 173 under the
Securities Act) is hereinafter referred to as the &#147;<B>Basic Prospectus</B>&#148;; and the Basic Prospectus, as supplemented by the prospectus supplement specifically relating to the Securities in the form first used to confirm sales of
Securities (or in the form first made available to the Underwriters by the Company to meet requests of purchasers pursuant to Rule 173 under the Securities Act), is hereinafter referred to as the &#147;<B>Prospectus</B>.&#148; The term
&#147;<B>preliminary prospectus</B>&#148; means a preliminary prospectus supplement specifically relating to the Securities together with the Basic Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Agreement, &#147;<B>free writing prospectus</B>&#148; has the meaning
set forth in Rule 405 under the Securities Act, &#147;<B>Time of Sale Prospectus</B>&#148; means the Basic Prospectus and the preliminary prospectus supplement contained in the Registration Statement together with any free writing prospectus set
forth in Schedule II hereto, and &#147;<B>broadly available road show</B>&#148; means a &#147;bona fide electronic road show&#148; as defined in Rule 433(h)(5) under the Securities Act that has been made available without restriction to any person.
As used herein, the terms &#147;Registration Statement,&#148; &#147;Basic Prospectus,&#148; &#147;preliminary prospectus,&#148; &#147;Time of Sale Prospectus&#148; and &#147;Prospectus&#148; shall include the documents, if any, incorporated by
reference therein. The terms &#147;<B>supplement</B>,&#148; &#147;<B>amendment</B>,&#148; and &#147;<B>amend</B>&#148; as used herein with respect to the Registration Statement, the Basic Prospectus, the Time of Sale Prospectus, any preliminary
prospectus or free writing prospectus shall include all documents subsequently filed by the Company with the Commission pursuant to the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;), that are deemed to be
incorporated by reference therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.</B> <I>Representations and Warranties of the Company</I>. The Company represents and warrants to
and agrees with each of the Underwriters that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Registration Statement has become effective; no stop order
suspending the effectiveness of the Registration Statement is in effect, and no proceedings for such purpose are pending before or threatened by the Commission. (A)&nbsp;At the time of filing the Registration Statement, (B)&nbsp;at the time of the
most recent amendment thereto for the purposes of complying with Section&nbsp;10(a)(3) of the Securities Act (whether such amendment was by posteffective amendment, incorporated report filed pursuant to Section&nbsp;13 or 15(d) of the Exchange Act
or form of prospectus) and (C)&nbsp;at the date hereof, the Securities, since their registration on the Registration Statement, have been and remain eligible for registration by the Company on a registration statement on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> pursuant to Rule 415. Rule 164(e)(2) applies to each free writing prospectus with respect to the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) (i) The Registration Statement, when it became effective, did not contain and, as amended or supplemented, if applicable,
when such amendment or supplement becomes effective, will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (ii)&nbsp;the
Registration Statement and the Prospectus comply and, as amended or supplemented, if applicable, will comply in all material respects with the Securities Act and the Trust Indenture Act of 1939, as amended ( the &#147;<B>Trust Indenture
Act</B>&#148;) and the applicable rules and regulations of the Commission thereunder, (iii)&nbsp;the Time of Sale Prospectus does not, and at the time of each sale of the Securities in connection with the offering when the Prospectus is not yet
available to prospective purchasers and at the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Closing Date (as defined in Section&nbsp;4), the Time of Sale Prospectus, as then amended or supplemented by the Company, if applicable, will not, contain any untrue statement of a material fact
or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, (iv)&nbsp;any preliminary prospectus filed as part of the Registration Statement as
originally filed or as part of any amendment thereto, or filed pursuant to Rule 424 under the Securities Act, complied when so filed in all material respects with the Securities Act and the Trust Indenture Act and the rules and regulations of the
Commission thereunder, (v)&nbsp;each broadly available road show, if any, when considered together with the Time of Sale Prospectus, does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading and (vi)&nbsp;the Prospectus does not contain, as of its date, and, as amended or supplemented, if applicable, as of the date of such amendment or
supplement, will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, except that the
representations and warranties set forth in this paragraph do not apply to statements or omissions in the Registration Statement, the Time of Sale Prospectus or the Prospectus based upon information relating to any Underwriter furnished to the
Company in writing by such Underwriter through you expressly for use therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The documents filed or are to be filed
pursuant to the Exchange Act and incorporated by reference in the Registration Statement, the Prospectus and the Time of Sale Prospectus, when they were filed with the Commission conformed or will conform in all material respects to the requirements
of the Exchange Act, and none of such documents contained or will contain any untrue statement of a material fact or omitted or will omit to state a material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Any free writing prospectus that the Company is required to file pursuant to
Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder. Each free writing prospectus that
the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or on behalf of or used or referred to by the Company complies or will comply in all material respects with the requirements of
the Securities Act and the applicable rules and regulations of the Commission thereunder. Except for the free writing prospectuses, if any, identified in Schedule II hereto, and electronic road shows, if any, each furnished to you before first use,
the Company has not prepared, used or referred to, and will not, without your prior consent, prepare, use or refer to, any free writing prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Company has been duly incorporated, is validly existing as a
corporation in good standing under the laws of the State of Delaware, has the corporate power and authority necessary to hold or own its property and to conduct its business as described in the Time of Sale Prospectus and the Prospectus and is duly
qualified to transact business and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified, be in
good standing or have such power or authority would not reasonably be expected to have a material adverse effect on the business, financial position, stockholders&#146; equity or results of operations of the Company and its subsidiaries taken as a
whole (a &#147;<B>Material Adverse Effect</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Each Significant Subsidiary (as defined below) of the Company
has been duly incorporated or organized, is validly existing in good standing (to the extent that such concept is applicable) under the laws of the jurisdiction of its incorporation or organization, has the corporate or other power and authority to
own its property and to conduct its business as described in the Time of Sale Prospectus and the Prospectus and is duly qualified to transact business and is in good standing in each jurisdiction in which the conduct of its business or its ownership
or leasing of property requires such qualification, except to the extent that the failure to be so qualified, be in good standing or have such power or authority would not reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect; all of the issued shares of capital stock or other equity interests, as applicable, of each Significant Subsidiary of the Company have been duly and validly authorized and issued, are fully paid and
<FONT STYLE="white-space:nowrap">non-assessable</FONT> and, except as disclosed in the Time of Sale Prospectus, are owned directly or indirectly by the Company, free and clear of all material liens, encumbrances, equities or claims. For purposes of
this Agreement, &#147;Significant Subsidiary&#148; means the subsidiaries listed in Schedule IV to this Agreement. The subsidiaries listed in Schedule IV to this Agreement are the only &#147;significant subsidiaries&#148; of the Company (as defined
in Rule <FONT STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X).</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Each
subsidiary that is required to be organized and licensed as an insurance company (each, an &#147;<B>Insurance Subsidiary</B>,&#148; and collectively the &#147;<B>Insurance Subsidiaries</B>&#148;) is duly organized and licensed as an insurance
company in the jurisdiction in which it is chartered or organized and is duly licensed or authorized as an insurer in each other jurisdiction where it is required to be so licensed or authorized to conduct its business as described in the Time of
Sale Prospectus and the Prospectus, except in each case where the failure to be so organized, licensed or authorized would not reasonably be expected to have a Material Adverse Effect; each of the Company and each Insurance Subsidiary has made all
required filings under applicable insurance company statutes and has filed all notices, reports, documents or other information required to be filed thereunder, except in each case where the failure to do so would not reasonably be expected to have
a Material Adverse Effect; each of the Company and each Insurance Subsidiary has all other necessary authorizations, approvals, orders, consents, licenses, certificates, permits, registrations and qualifications, of and from all insurance regulatory
authorities necessary to conduct their respective </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
existing businesses as described in the Time of Sale Prospectus and the Prospectus, except where the failure to have such authorizations, approvals, orders, consents, licenses, certificates,
permits, registrations or qualifications (individually or in the aggregate) would not reasonably be expected to have a Material Adverse Effect, except as set forth in or contemplated in the Time of Sale Prospectus and the Prospectus; none of the
Company or any Insurance Subsidiary has received any notification from any insurance regulatory authority to the effect that any additional authorization, approval, order, consent, license, certificate, permit, registration or qualification from any
insurance regulatory authority is needed to be obtained by any of the Company or any Insurance Subsidiary other than in any case where the failure to acquire such additional authorization, approval, order, consent, license, certificate, permit,
registration or qualification (individually or in the aggregate) would not reasonably be expected to have a Material Adverse Effect; except as set forth in the Time of Sale Prospectus and the Prospectus, no subsidiary of the Company is currently
prohibited, directly or indirectly, under any law, rule, regulation, agreement or other instrument to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution on such subsidiary&#146;s capital
stock or similar ownership interest, from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary&#146;s properties or assets to the Company or any other subsidiary of the Company
as would reasonably be expected to have a Material Adverse Effect; and except as set forth in the Time of Sale Prospectus and the Prospectus, no insurance regulatory authority having jurisdiction over any Insurance Subsidiary has issued any order or
decree impairing, restricting or prohibiting (A)&nbsp;the payment of dividends by any Insurance Subsidiary to its parent or the payment of dividends by such parent to the Company (directly or indirectly through one or more intermediate holding
companies directly or indirectly wholly owned by the Company), or (B)&nbsp;the continuation of the business of the Company or any of the Insurance Subsidiaries in all material respects as presently conducted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) This Agreement has been duly authorized, executed and delivered by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Indenture has been duly authorized by the Company and, at the Closing Date, will have been duly executed and delivered
by the Company and, when duly executed and delivered in accordance with its terms by each of the parties thereto, will constitute a valid and legally binding agreement of the Company enforceable against the Company in accordance with its terms,
except as to the enforcement thereof may be limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general application affecting the rights and remedies of creditors and to general principles of
equity (collectively, the &#147;<B>Enforceability Exceptions</B>&#148;); and upon effectiveness of the Registration Statement, the Indenture was or will have been duly qualified under the Trust Indenture Act; the Indenture will conform to the
description thereof in the Registration Statement, the Time of Sale Prospectus and the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) The Securities have been duly authorized by the Company and, when the
Securities are issued and delivered to and paid for by the Underwriters pursuant to this Agreement such Securities will have been duly executed, authenticated, issued and delivered (assuming their authentication by the Trustee, as provided in the
Indenture), and paid for as provided herein, and will constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their terms, subject as to enforcement, to the Enforceability Exceptions; the
Securities will be substantially in the form contemplated by the Indenture; and the Indenture and the Securities will conform in all material respects to the descriptions thereof contained in the Time of Sale Prospectus and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) The authorized capital stock of the Company conforms in all material respects to the description thereof contained in each
of the Time of Sale Prospectus and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) The outstanding shares of capital stock of the Company have been
duly authorized and are validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and are not subject to any preemptive rights. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) The execution and delivery by the Company of, and the performance by the Company of its obligations under, this Agreement
and the Indenture, the sale of the Securities, the consummation of any other of the transactions herein and therein contemplated or the fulfillment of the terms hereof and thereof will not (i)&nbsp;conflict with or result in a breach or violation of
any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any property, right or asset of the Company or any of its subsidiaries pursuant to, any indenture,
mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any property or asset of the Company or any
of its subsidiaries is subject, (ii)&nbsp;result in any violation of the provisions of the certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Company or (iii)&nbsp;result in any violation of any law or any
judgment, order or decree of any governmental body, agency or court having jurisdiction over the Company or any subsidiary, except, in the case of clauses (i)&nbsp;and (iii) above, for any such conflict, breach, violation, default, lien, charge,
encumbrance, judgment, order or decree that would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. No consent, approval, authorization, order, registration or qualification of or with any court or
arbitrator or governmental or regulatory body or agency is required for the execution, delivery and performance by the Company of this Agreement and the Indenture and consummation of the transactions contemplated hereby and thereby, except such as
may be required for the registration of the Securities under the Securities Act, such consents, approvals, authorizations, orders and registrations or qualifications as have been obtained or may be required by the Financial Industry Regulatory
Authority, Inc. (&#147;<B>FINRA</B>&#148;) and such as may be required by the securities or Blue Sky laws of the various states and foreign securities laws in connection with the purchase and distribution of the Securities by the Underwriters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) There are no legal, governmental or regulatory investigations, actions,
demands, claims, suits, arbitrations, inquiries or proceedings (&#147;<B>Actions</B>&#148;) pending or, to the Company&#146;s knowledge, threatened to which the Company or any of its subsidiaries is a party or to which any of the property or assets
of the Company or any of its subsidiaries is or may be subject (i)&nbsp;other than Actions described in all material respects in the Time of Sale Prospectus and Actions that would not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect, or a material adverse effect on the power or ability of the Company to perform its obligations under this Agreement or to consummate the transactions contemplated by the Time of Sale Prospectus or (ii)&nbsp;that are
required to be described in the Registration Statement or the Prospectus under the Securities Act and are not so described in the Registration Statement, the Time of Sale Prospectus and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) The Company is not, and after giving effect to the offering and sale of the Securities and the application of the proceeds
thereof as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus will not be, required to register as an &#147;investment company&#148; as such term is defined in the Investment Company Act of 1940, as amended, and
the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) The Company and its subsidiaries (i)&nbsp;are in compliance with any
and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#147;<B>Environmental
Laws</B>&#148;), (ii)&nbsp;have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii)&nbsp;are in compliance with all terms and conditions of any such
permit, license or approval, except where such noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses or approvals would
not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) There are no costs or
liabilities associated with Environmental Laws (including, without limitation, any capital or operating expenditures required for <FONT STYLE="white-space:nowrap">clean-up,</FONT> closure of properties or compliance with Environmental Laws or any
permit, license or approval, any related constraints on operating activities and any potential liabilities to third parties) which would reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) There are no contracts, agreements or understandings between the Company and any person granting such person the right to
require the Company to file a registration statement under the Securities Act with respect to any securities of the Company or to require the Company to include such securities with the Securities registered pursuant to the Registration Statement,
other than as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) The financial statements (including the related notes thereto) of the
Company and its consolidated subsidiaries incorporated by reference in the Registration Statement, the Time of Sale Prospectus and the Prospectus comply in all material respects with the requirements of the Securities Act, including the applicable
accounting requirements of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Securities Act (&#147;<B>Regulation <FONT STYLE="white-space:nowrap">S-X</FONT></B>&#148;), and present fairly in all material respects the consolidated
financial position of the Company and its subsidiaries as of the dates indicated and the results of their operations and the changes in their cash flows for the periods specified; such financial statements have been prepared in conformity with
generally accepted accounting principles in the United States (&#147;<B>GAAP</B>&#148;) applied on a consistent basis throughout the periods covered thereby; the other financial information included or incorporated by reference in the Registration
Statement, the Time of Sale Prospectus and the Prospectus has been derived from the accounting records of the Company and its subsidiaries and presents fairly in all material respects the information shown thereby; and the selected financial data
included or incorporated by reference in the Time of Sale Prospectus and the Prospectus fairly present, on the basis stated in the Time of Sale Prospectus and the Prospectus, the information included therein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) PricewaterhouseCoopers LLP, who has certified certain financial statements of the Company and its subsidiaries, is an
independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board and as required by the Securities
Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect,
(i)&nbsp;each employee benefit plan, within the meaning of Section&nbsp;3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#147;<B>ERISA</B>&#148;), for which the Company or any of its subsidiaries would have any liability
(each, a &#147;<B>Plan</B>&#148;) has been maintained in compliance in all respects with the requirements of all applicable statutes, rules and regulations including ERISA and the Internal Revenue Code of 1986, as amended (the
&#147;<B>Code</B>&#148;); (ii) no prohibited transaction, within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code, has occurred with respect to any Plan excluding transactions effected pursuant to a statutory or
administrative exemption; (iii)&nbsp;for each Plan that is subject to the funding rules of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, no such Plan has failed (whether or not waived), or is reasonably expected to fail, to satisfy the
minimum funding standards (within the meaning of Section&nbsp;302 of ERISA or Section&nbsp;412 of the Code) applicable to such Plan; (iv)&nbsp;no such Plan is, or is reasonably expected to be, in &#147;at risk status&#148; (within the meaning of
Section&nbsp;303(i) of ERISA) or &#147;endangered status&#148; or &#147;critical status&#148; (within the meaning of Section&nbsp;305 of ERISA); (v) no &#147;reportable event&#148; (within the meaning of Section&nbsp;4043(c) of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
ERISA) has occurred or is reasonably expected to occur with respect to any such Plan; (vi)&nbsp;each Plan that is intended to be qualified under Section&nbsp;401(a) of the Code is so qualified,
nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification, and the Company shall undertake to maintain such qualification of each Plan; (vii)&nbsp;except as described in the Time of Sale
Prospectus and the Prospectus, the fair market value of the assets under each qualified defined benefit pension plan (excluding for these purposes accrued but unpaid contributions) exceeds the present value of all benefits accrued under such plan
(determined based on those assumptions used to fund such plan) and (viii)&nbsp;neither the Company nor any of its subsidiaries has incurred, nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan
or premiums to the Pension Benefit Guaranty Corporation, in the ordinary course and without default) in respect of a Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) (i) None of the Company or its subsidiaries or affiliates under the control of the Company (&#147;<B>controlled
affiliates</B>&#148;), or any director, officer, or employee thereof, or, to the Company&#146;s knowledge, any agent or representative of the Company or of any of its subsidiaries or controlled affiliates, has taken or will take any action in
furtherance of an offer, payment, promise to pay, or authorization or approval of the payment, giving or receipt of money, property, gifts or anything else of value, directly or indirectly, to any government official (including any officer or
employee of a government or government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate
for political office) in order to influence official action or secure an improper advantage, or to any person in violation of any applicable anti-corruption laws, including the Foreign Corrupt Practices Act of 1977, as amended; and (ii)&nbsp;the
Company and its subsidiaries and controlled affiliates have conducted their businesses in compliance with applicable anti-corruption laws and have instituted and maintained and will continue to maintain policies and procedures reasonably designed to
promote and achieve compliance with such laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) The operations of the Company and its subsidiaries are and have been
conducted at all times in material compliance with all applicable financial recordkeeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by Providing Appropriate
Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and the applicable anti-money laundering statutes of jurisdictions where the Company and its subsidiaries conduct business, the rules and regulations thereunder and
any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#147;<B>Anti-Money Laundering Laws</B>&#148;), and no action, suit or proceeding by or before any court or
governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the best knowledge of the Company, threatened. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) (i) None of the Company, any of its subsidiaries, or any director,
officer, or employee thereof, or, to the Company&#146;s knowledge, any agent, controlled affiliate or representative of the Company or any of its subsidiaries, is an individual or entity (&#147;<B>Person</B>&#148;) that is, or is owned or controlled
by one or more Persons that are: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. the subject of any sanctions administered or enforced by the U.S. Department of
Treasury&#146;s Office of Foreign Assets Control, the United Nations Security Council, the European Union, His Majesty&#146;s Treasury, or other relevant sanctions authority (collectively, &#147;<B>Sanctions</B>&#148;), or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. located, organized or resident in a country or territory that is the subject of Sanctions (including, without limitation,
the Crimea, Donetsk and Luhansk regions of Ukraine, Cuba, Iran, North Korea and Syria). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) For the past 5 years, the
Company and its subsidiaries have not knowingly engaged in, are not now knowingly engaged in, and will not knowingly engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or
transaction is or was the subject of Sanctions in a manner that would violate any Sanctions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) Subsequent to the
respective dates as of which information is given in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus, (i)&nbsp;the Company and its subsidiaries have not incurred any material liability or obligation, direct or
contingent, nor entered into any material transaction; (ii)&nbsp;the Company has not purchased any of its outstanding capital stock, nor declared, set aside for payment, paid or otherwise made any dividend or distribution of any kind on its capital
stock; (iii)&nbsp;there has not been any material change in the capital stock, short-term debt or long-term debt of the Company and its subsidiaries taken as a whole, or any material adverse change, or any development involving a prospective
material adverse change, in or affecting the business, assets, financial position, shareholder&#146;s equity, results of operations or prospects of the Company and its subsidiaries taken as a whole; and (iv)&nbsp;neither the Company nor any of its
subsidiaries has sustained any material loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court
or arbitrator or governmental or regulatory authority; except in each case as described in the Time of Sale Prospectus and the Prospectus (exclusive of any amendment or supplement thereto). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) The Company and its subsidiaries have good and marketable title in fee
simple to all real property and good and marketable title to all personal property owned by them that are material to the business of the Company and its subsidiaries, in each case free and clear of all liens, encumbrances and defects except such as
are described in the Time of Sale Prospectus or such as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company or its subsidiaries; and all real
property held under lease by the Company or its subsidiaries that are material to the business of the Company and its subsidiaries are held under valid, subsisting and enforceable leases with such exceptions as do not materially interfere with the
use made and proposed to be made of such property by the Company and its subsidiaries, in each case, except as described in the Time of Sale Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa) The Company and its subsidiaries&#146; information technology hardware and software assets (collectively, &#147;<B>IT
Systems</B>&#148;) are adequate for the operation of the business of the Company and its subsidiaries as currently conducted. The Company and its subsidiaries have implemented and maintain commercially reasonable policies, procedures, and safeguards
to maintain the security of their confidential data (including all confidential personally identifiable data (&#147;<B>Confidential Data</B>&#148;)) collected, stored or owned by them in connection with their businesses. Except as described in the
Time of Sale Prospectus, during the last three years, there have been no breaches or violations of the Company&#146;s IT Systems with respect to any Confidential Data that have had a material adverse effect on the business of the Company and its
subsidiaries. The Company and its subsidiaries are presently in material compliance with all laws and regulations and any court orders applicable to the security of IT Systems and Confidential Data. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb) (i) The Company and its subsidiaries own or possess or have the right to use, or can acquire on reasonable terms, all
material patents, patent applications, patent rights, licenses, inventions, copyrights and copyrightable works, know how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or
procedures), trademarks, trademark registrations, service marks, service mark registrations, domain names and other source indicators, trade names, proprietary or confidential information and all other worldwide intellectual property, industrial
property and proprietary rights (collectively, &#147;<B>Intellectual Property</B>&#148;) currently used by them in the conduct of the business now operated by them, (ii)&nbsp;the Company&#146;s and its subsidiaries&#146; conduct of their business
does not infringe, misappropriate or otherwise violate any Intellectual Property right of any person which, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect, (iii)&nbsp;neither the Company nor any of
its subsidiaries has received any notice of infringement, misappropriation, violation of or conflict with asserted rights of others with respect to any Intellectual Property which, individually or in the aggregate, if the subject of an unfavorable
decision, ruling or finding, would reasonably be expected to have a Material Adverse Effect and (iv)&nbsp;to the knowledge of the Company, the Intellectual Property of the Company and its subsidiaries is not being infringed, misappropriated or
violated by any person which, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc) No material labor dispute with the employees of the Company or any of
its subsidiaries exists, except as described in the Time of Sale Prospectus, or, to the knowledge of the Company, is imminent; and the Company is not aware of any existing, threatened or imminent labor disturbance by the employees of any of its
principal suppliers, manufacturers or contractors that would reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd) The Company and each of its subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as are prudent and customary in the businesses in which they are engaged; all policies of insurance and fidelity or surety bonds insuring the Company or any of its subsidiaries or their respective businesses,
assets, officers and directors (the &#147;<B>Policies and Instruments</B>&#148;) are, to the knowledge of the Company, in full force and effect; the Company and its consolidated subsidiaries are in compliance with the terms of the Policies and
Instruments in all material respects; and neither the Company nor any of its subsidiaries has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its business at a cost that would not reasonably be expected to have a Material Adverse Effect, except as described in the Time of Sale Prospectus and the Prospectus (exclusive of any amendment
or supplement thereto). Except as would not reasonably be expected to have a Material Adverse Effect, (i)&nbsp;there are no claims by the Company or any of its subsidiaries under any of the Policies and Instruments as to which any insurance company
is denying liability or defending under a reservation of rights clause and (ii)&nbsp;neither the Company nor any of its subsidiaries has been refused any insurance coverage sought or applied for. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee) The Company and its subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state or foreign regulatory authorities necessary to conduct their respective businesses, except where the failure to possess the same would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect; and neither
the Company nor any of its subsidiaries has received any notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit which, individually or in the aggregate, if the subject of an unfavorable
decision, ruling or finding, would reasonably be expected to have a Material Adverse Effect, except as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus (exclusive of any amendment or supplement thereto). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff) Except as described in the Time of Sale Prospectus and the Prospectus
(exclusive of any amendment or supplement thereto), the Company and each of its subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with GAAP, including, but not limited to internal accounting controls sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with
management&#146;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii)&nbsp;access to assets is
permitted only in accordance with management&#146;s general or specific authorization; (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any
differences; and (v)&nbsp;the interactive data in eXtensible Business Reporting Language incorporated by reference in the Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance
with the Commission&#146;s rules and guidelines applicable thereto. Except as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus, since the end of the Company&#146;s most recent audited fiscal year, there has
been (i)&nbsp;no material weakness in the Company&#146;s internal control over financial reporting (whether or not remediated) and (ii)&nbsp;no change in the Company&#146;s internal control over financial reporting that has materially affected, or
is reasonably likely to materially affect, the Company&#146;s internal control over financial reporting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg) The Company
and each of its subsidiaries have filed all federal, state, local and foreign tax returns required to be filed through the date of this Agreement or have requested extensions thereof (except where the failure to file would not, individually or in
the aggregate, have a Material Adverse Effect) and have paid all taxes required to be paid thereon (except for cases in which the failure to file or pay would not have a Material Adverse Effect or except as currently being contested in good faith
and for which reserves required by GAAP have been created in the financial statements of the Company), and no tax deficiency has been determined adversely to the Company or any of its subsidiaries which has had (nor does the Company nor any of its
subsidiaries have any notice or knowledge of any tax deficiency which would reasonably be expected to be determined adversely to the Company or its subsidiaries and which would reasonably be expected to have) a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh) The discussion set forth in the Time of Sale Prospectus and the Prospectus under the caption &#147;Certain Material United
States Federal Income Tax Considerations&#148; fairly summarizes in all material respects (subject to the limitations and qualifications set forth therein) the United States federal income tax consequences of the acquisition, ownership and
disposition of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Neither the Company nor any of its subsidiaries is a party to any contract, agreement
or understanding with any person (other than this Agreement) that would give rise to a valid claim against the Company or any of its subsidiaries or any Underwriter for a brokerage commission, finder&#146;s fee or like payment in connection with the
offering and sale of the Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj) No relationship, direct or indirect, exists between or among the
Company or any of its subsidiaries, on the one hand, and the directors, officers, stockholders, customers, suppliers or other affiliates of the Company or any of its subsidiaries, on the other, that is required by the Securities Act to be described
in each of the Registration Statement and the Prospectus and that is not so described in such documents and in the Time of Sale Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk) The Company has not taken, directly or indirectly, any action designed to or that could reasonably be expected to cause or
result in any stabilization or manipulation of the price of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll) Nothing has come to the attention of the
Company that has caused the Company to believe that the statistical and market-related data included or incorporated by reference in the Registration Statement, the Time of Sale Prospectus and the Prospectus is not based on or derived from sources
that are reliable and accurate in all material respects.<SUP STYLE="font-size:75%; vertical-align:top"> </SUP> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm) The
material forward-looking statements (within the meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Exchange Act) included or incorporated by reference in the Time of Sale Prospectus, the Prospectus or any road show has
been so included or incorporated by reference on a reasonable basis and in good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.</B> <I>Agreements to Sell and Purchase</I>.
The Company hereby agrees to sell to the several Underwriters, and each Underwriter, upon the basis of the representations and warranties herein contained, but subject to the conditions hereinafter stated, agrees, severally and not jointly, to
purchase from the Company the respective principal amount of Securities set forth opposite such Underwriter&#146;s name on Schedule I hereto at a price equal to 99.000% of the principal amount thereof (the &#147;<B>Purchase Price</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company hereby agrees that, without your prior written consent, it will not, during the period ending 30 days after the date of this
Agreement, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise dispose of, directly or indirectly, any securities
of the Company which are substantially similar to the Securities, including any securities that are convertible into or exchangeable for, or that represent rights to receive, the Securities or securities that are substantially similar to the
Securities, or file any registration statement with the Commission relating to the offering of any such securities; <I>provided</I>, however, that the foregoing shall not apply to the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.</B> <I>Terms of Public Offering</I>. The Company is advised by you that the Underwriters propose to make a public offering of their
respective portions of the Securities upon the terms and conditions set forth in the Time of Sale Prospectus and the Prospectus. The Company acknowledges and agrees that the Underwriters may offer and sell the Securities to or through an affiliate
of an Underwriter and that any such affiliate may offer and sell the Securities purchased by it to or through any Underwriter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.</B> <I>Payment and Delivery</I>. Payment for and delivery of the Securities shall be
made to the Company in Federal or other funds immediately available in New York City against delivery of such Securities for the respective accounts of the several Underwriters at 10:00&nbsp;a.m., New York City time, on March 26, 2025, or at such
other time on the same or such other date, not later than April&nbsp;1, 2025, as shall be designated in writing by you. The time and date of such payment are hereinafter referred to as the &#147;<B>Closing Date</B>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment for the Securities to be purchased on the Closing Date shall be made by wire transfer in immediately available funds to the account
specified by the Company to the Underwriters against delivery to the nominee of The Depository Trust Company, for the account of the Underwriters, of one or more global notes representing the Securities (collectively, the &#147;<B>Global
Note</B>&#148;) purchased on such date, with any transfer taxes payable in connection with the sale of such Securities duly paid by the Company. The Global Note will be made available for inspection by the Underwriters not later than 1:00&nbsp;p.m.,
New York City time, on the business day prior to the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.</B> <I>Conditions to the Underwriters</I><I>&#146;</I><I>
Obligations</I>. The several obligations of the Underwriters to purchase and pay for the Securities on the Closing Date are subject to the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subsequent to the execution and delivery of this Agreement and prior to the Closing Date: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) there shall not have occurred any downgrading, nor shall any notice have been given of any intended or potential
downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded any of the securities of the Company or any of its subsidiaries by any &#147;nationally recognized statistical
rating organization,&#148; as such term is defined in Section&nbsp;3(a)(62) of the Exchange Act; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) there shall not
have occurred any change, or any development involving a prospective change, in the financial condition, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Time of Sale
Prospectus that, in your judgment, (after consultation with the Company, if practicable) is material and adverse and that makes it, in your judgment, impracticable to market the Securities on the terms and in the manner contemplated in the Time of
Sale Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) No order suspending the effectiveness of the Registration Statement shall be in effect, and no
proceeding for such purpose, pursuant to Rule 401(g)(2) or pursuant to Section&nbsp;8A under the Securities Act, shall be pending before or, to the knowledge of the Company, threatened by the Commission; the Prospectus and each free writing
prospectus shall have been timely filed with the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Commission under the Securities Act (in the case of an free writing prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with Section&nbsp;6(a) hereof; and
all requests by the Commission for additional information shall have been complied with to the reasonable satisfaction of the Underwriters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Underwriters shall have received on the Closing Date a certificate, dated the Closing Date and signed by an executive
officer of the Company, to the effect set forth in Section&nbsp;5(a)(i) above and to the effect that the representations and warranties of the Company contained in this Agreement are true and correct as of the Closing Date and that the Company has
complied with all of the agreements and satisfied all of the conditions on its part to be performed or satisfied hereunder on or before the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Underwriters shall have received on the Closing Date an opinion and negative assurance letter of Willkie
Farr&nbsp;&amp; Gallagher LLP, outside counsel for the Company, dated the Closing Date, to the effect set forth in Annex&nbsp;A. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Underwriters shall have received on the Closing Date an opinion of Jos&eacute; Ram&oacute;n Gonz&aacute;lez, Chief
Legal Officer and Secretary of the Company, dated the Closing Date, to the effect set forth in Annex B. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The
Underwriters shall have received on the Closing Date an opinion and disclosure letter of Sullivan&nbsp;&amp; Cromwell LLP, counsel for the Underwriters, dated the Closing Date with respect to such matters as you may reasonably request. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The opinions described in Sections 5(d) and 5(e) above shall be rendered to the Underwriters at the request of the Company and shall so state
therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) The Underwriters shall have received, on each of the date hereof and the Closing Date, a letter dated the
date hereof or the Closing Date, as the case may be, in form and substance satisfactory to the Underwriters, from PricewaterhouseCoopers LLP, independent public accountants, containing statements and information of the type ordinarily included in
accountants&#146; &#147;comfort letters&#148; to underwriters with respect to the financial statements and certain financial information contained or incorporated by reference in the Registration Statement, the Time of Sale Prospectus and the
Prospectus; <I>provided</I> that the letter delivered on the Closing Date shall use a <FONT STYLE="white-space:nowrap">&#147;cut-off</FONT> date&#148; not earlier than the date hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) The Underwriters shall have received, on and as of the Closing Date, satisfactory evidence of the good standing of the
Company and its Significant Subsidiaries in their respective jurisdictions of organization (to the extent that such concept is applicable) and their good standing in such other jurisdictions as the Underwriters may reasonably request, in each case
in writing or any standard form of telecommunication, from the appropriate governmental authorities of such jurisdictions, provided that the evidence of good standing for those entities except for the Company may be as of any date from the date
hereof through and including the Closing Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Underwriters shall have received, on each of the date hereof and the
Closing Date, a certificate of the Chief Financial Officer of the Company dated the date hereof or the Closing Date, as applicable, in form and substance satisfactory to you, stating, as of such date, the conclusions and findings of such individual,
in his or her capacity as Chief Financial Officer of the Company, with respect to the financial information and such other matters as reasonably requested by you. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.</B> <I>Covenants of the Company</I>.<SUP STYLE="font-size:75%; vertical-align:top"> </SUP>The Company covenants with each Underwriter as
follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company will file the final Prospectus with the Commission within the time periods specified by Rule
424(b) and Rule 430B under the Securities Act and will file any free writing prospectus to the extent required by Rule 433 under the Securities Act; and the Company will file promptly all reports and any definitive proxy or information statements
required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus is required in connection with
the offering or sale of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) To furnish to you, without charge, a conformed copy of the Registration
Statement (without exhibits thereto) and to furnish to you in New York City, without charge, prior to 10:00&nbsp;a.m. New York City time on the business day next succeeding the date of this Agreement and during the period mentioned in
Section&nbsp;6(f) or 6(g) below, as many copies of the Time of Sale Prospectus, the Prospectus and any supplements and amendments thereto or to the Registration Statement as you may reasonably request. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Before amending or supplementing the Registration Statement, the Time of Sale Prospectus or the Prospectus, to furnish to
you a copy of each such proposed amendment or supplement and not to file any such proposed amendment or supplement to which you reasonably object, and to file with the Commission within the applicable period specified in Rule&nbsp;424(b) under the
Securities Act any prospectus required to be filed pursuant to such Rule. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) To furnish to you a copy of each proposed
free writing prospectus to be prepared by or on behalf of, used by, or referred to by the Company and not to use or refer to any proposed free writing prospectus to which you reasonably object. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Not to take any action that would result in an Underwriter or the
Company being required to file with the Commission pursuant to Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of the Underwriter that the Underwriter otherwise would not have been required to file thereunder.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) If the Time of Sale Prospectus is being used to solicit offers to buy the Securities at a time when the Prospectus is
not yet available to prospective purchasers and any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Time of Sale Prospectus in order to make the statements therein, in the light of the
circumstances, not misleading, or if during such time any event shall occur or condition exist as a result of which the Time of Sale Prospectus conflicts with the information contained in the Registration Statement then on file, or if, in the
reasonable opinion of counsel for the Underwriters, it is necessary to amend or supplement the Time of Sale Prospectus to comply with applicable law, forthwith to prepare, file with the Commission and furnish, at its own expense, to the Underwriters
and to any dealer upon request, either amendments or supplements to the Time of Sale Prospectus so that the statements in the Time of Sale Prospectus as so amended or supplemented will not, in the light of the circumstances when the Time of Sale
Prospectus is delivered to a prospective purchaser, be misleading or so that the Time of Sale Prospectus, as amended or supplemented, will no longer conflict with the Registration Statement, or so that the Time of Sale Prospectus, as amended or
supplemented, will comply with applicable law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) If, during such period after the first date of the public offering of
the Securities as in the reasonable opinion of counsel for the Underwriters, the Prospectus (or in lieu thereof the notice referred to in Rule 173(a) of the Securities Act) is required by law to be delivered in connection with sales by an
Underwriter or dealer, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus in order to make the statements therein, in the light of the circumstances when the Prospectus (or in lieu
thereof the notice referred to in Rule 173(a) of the Securities Act) is delivered to a purchaser, not misleading, or if, in the reasonable opinion of counsel for the Underwriters, it is necessary to amend or supplement the Prospectus to comply with
applicable law, forthwith to prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to the dealers (whose names and addresses you will furnish to the Company) to which Securities may have been sold by the
Underwriters and to any other dealers upon request, either amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances when the Prospectus (or in lieu
thereof the notice referred to in Rule 173(a) of the Securities Act) is delivered to a purchaser, be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) To endeavor to qualify the Securities for offer and sale under the
securities or Blue Sky laws of such jurisdictions as you shall reasonably request, <I>provided </I>that in connection therewith, the Company shall not be required to (i)&nbsp;qualify to do business in any jurisdiction where it is not now so
qualified, (ii)&nbsp;subject itself to taxation in any such jurisdiction where it is not now so subject and (iii)&nbsp;take any action that would subject it to services of process in suits, other than those arising out of the offering or sale of the
Securities, in any jurisdiction where it is not now so subject. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) To make generally available to the Company&#146;s
security holders and to you as soon as reasonably practicable an earnings statement (which need not be audited) covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the date of this
Agreement which shall satisfy the provisions of Section&nbsp;11(a) of the Securities Act and the rules and regulations of the Commission thereunder (including, at the Company&#146;s option, Rule 158 of the Securities Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.</B> <I>Expenses</I>. Whether or not the transactions contemplated in this Agreement are consummated or this Agreement is terminated, the
Company agrees to pay or cause to be paid all expenses incident to the performance of their obligations under this Agreement, including: (i)&nbsp;the fees, disbursements and expenses of the Company&#146;s counsel and the Company&#146;s accountants
in connection with the registration and delivery of the Securities under the Securities Act and all other fees or expenses in connection with the preparation and filing of the Registration Statement, any preliminary prospectus, the Time of Sale
Prospectus, the Prospectus, any free writing prospectus prepared by or on behalf of, used by, or referred to by the Company and amendments and supplements to any of the foregoing, including all printing costs associated therewith, and the mailing
and delivering of copies thereof to the Underwriters and dealers, in the quantities hereinabove specified, (ii)&nbsp;all costs and expenses related to the transfer and delivery of the Securities to the Underwriters, including any transfer, stamp,
value added or similar taxes or duties payable thereon, (iii)&nbsp;the cost of producing, printing and distributing any Blue Sky or Legal Investment memorandum in connection with the offer and sale of the Securities under state and/or foreign
securities laws and all expenses in connection with the qualification of the Securities for offer and sale under state securities laws and/or foreign securities laws as provided in Section&nbsp;6(h) hereof or the determination of the conditions
under which such registration or qualification need not be obtained in order to offer and sell Securities in such jurisdictions, including filing fees and the reasonable fees and disbursements of counsel for the Underwriters (including local counsel
in each such foreign jurisdiction) in connection with such qualification or determination and in connection with the Blue Sky or Legal Investment memorandum, (iv)&nbsp;all filing fees and the reasonable fees and disbursements of counsel to the
Underwriters incurred in connection with the review and qualification of the offering of the Securities by FINRA, if any, (v)&nbsp;the cost of preparing the Securities, (vi)&nbsp;the costs and charges of any transfer agent, registrar, depositary or
dividend disbursement agent for the Securities (including related fees and expenses of any counsel to such parties incurred in connection with the Securities), (vii) any fees charged by rating agencies for rating the Securities, (viii)&nbsp;the
costs and expenses of the Company relating to investor presentations on any &#147;road show&#148; undertaken in connection with the marketing of the offering of the Securities, including, without limitation, expenses associated with the preparation
or dissemination of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
electronic road show, expenses associated with the production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations with
the prior approval of the Company, travel and lodging expenses of the representatives and officers of the Company and any such consultants, and the cost of any aircraft chartered in connection with the road show, <I>provided</I>, however, that the
Underwriters shall pay or reimburse the Company half of the cost of any aircraft chartered in connection with the road show, (ix)&nbsp;the document production charges and expenses associated with printing this Agreement, and (x)&nbsp;all other costs
and expenses incident to the performance of the obligations of the Company hereunder for which provision is not otherwise made in this Section. It is understood, however, that except as provided in this Section, Section&nbsp;9 entitled
&#147;Indemnity and Contribution&#148; and the last paragraph of Section&nbsp;11 below, the Underwriters will pay all of their own costs and expenses, including fees and disbursements of their counsel, stock transfer taxes payable on resale of any
of the Securities by them and any advertising expenses connected with any offers they may make. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.</B> <I>Covenants of the
Underwriters</I>. Each Underwriter severally covenants with the Company not to take any action that would result in the Company being required to file with the Commission under Rule 433(d) a free writing prospectus prepared by or on behalf of such
Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.</B>
<I>Indemnity and Contribution</I>. (a)&nbsp;The Company agrees to indemnify and hold harmless each Underwriter, each person, if any, who controls any Underwriter within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20
of the Exchange Act, and each affiliate of each Underwriter within the meaning of Rule&nbsp;405 under the Securities Act from and against any and all losses, claims, damages and liabilities (including, without limitation, any legal or other expenses
reasonably incurred in connection with defending or investigating any such action or claim) that arise out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or any
amendment thereof, any preliminary prospectus, the Time of Sale Prospectus or any amendment or supplement thereto, any issuer free writing prospectus as defined in Rule 433(h) under the Securities Act, any Company information that the Company has
filed, or is required to file, pursuant to Rule&nbsp;433(d) under the Securities Act, any &#147;road show&#148; as defined in Rule 433(h) under the Securities Act (a &#147;<B>road show</B>&#148;) or the Prospectus or any amendment or supplement
thereto, or arise out of or are based upon any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as such losses, claims, damages or
liabilities arise out of or are based upon any such untrue statement or omission or alleged untrue statement or omission based upon information relating to any Underwriter furnished to the Company in writing by such Underwriter through you expressly
for use therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the
Company, the directors of the Company, the officers of the Company who sign the Registration Statement and each person, if any, who controls the Company within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the
Exchange Act from and against any and all losses, claims, damages and liabilities (including, without limitation, any legal or other expenses reasonably incurred in connection with defending or investigating any such action or claim) that arise out
of or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or any amendment thereof, any preliminary prospectus, the Time of Sale Prospectus or any amendment or supplement
thereto, any issuer free writing prospectus as defined in Rule 433(h) under the Securities Act, any Company information that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act, any road show or the
Prospectus or any amendment or supplement thereto, or arise out of or are based upon any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, but only
with reference to information relating to such Underwriter furnished to the Company in writing by such Underwriter through you expressly for use in the Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, any issuer free
writing prospectus, road show or the Prospectus or any amendment or supplement thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) In case any proceeding (including any
governmental investigation) shall be instituted involving any person in respect of which indemnity may be sought pursuant to Section&nbsp;9(a) or 9(b), such person (the &#147;<B>indemnified party</B>&#148;) shall promptly notify the person against
whom such indemnity may be sought (the &#147;<B>indemnifying party</B>&#148;) in writing and the indemnifying party, upon request of the indemnified party, shall retain counsel reasonably satisfactory to the indemnified party to represent the
indemnified party and any others the indemnifying party may designate in such proceeding and shall pay the fees and disbursements of such counsel related to such proceeding. In any such proceeding, any indemnified party shall have the right to
retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless (i)&nbsp;the indemnifying party and the indemnified party shall have mutually agreed to the retention of such counsel or
(ii)&nbsp;the named parties to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified party and representation of both parties by the same counsel would be inappropriate due to actual or
potential differing interests between them. It is understood that the indemnifying party shall not, in respect of the legal expenses of any indemnified party in connection with any proceeding or related proceedings in the same jurisdiction, be
liable for (i)&nbsp;the fees and expenses of more than one separate firm (in addition to any local counsel) for all Underwriters and all persons, if any, who control any Underwriter within the meaning of either Section&nbsp;15 of the Securities Act
or Section&nbsp;20 of the Exchange Act or who are affiliates of any Underwriter within the meaning of Rule&nbsp;405 under the Securities Act, and (ii)&nbsp;the fees and expenses of more than one separate firm (in addition to any local counsel) for
the Company, its directors, its officers who sign the Registration Statement and each person, if any, who controls the Company within the meaning of either such Section, and that all such fees and expenses shall be reimbursed as they are incurred.
In the case of any such separate firm for the Underwriters and such control persons and affiliates of any Underwriter, such firm shall be designated in writing by you. In the case of any such separate firm for the Company, and such directors,
officers and control persons of the Company, such firm shall be designated in writing by the Company. The indemnifying party shall not be liable for any settlement of any proceeding effected </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
without its written consent, which consent shall not be unreasonably withheld, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to
indemnify the indemnified party from and against any loss or liability by reason of such settlement or judgment. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or
threatened proceeding in respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party, unless such settlement includes an unconditional release of such indemnified
party from all liability on claims that are the subject matter of such proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) To the extent the indemnification provided for in
Section&nbsp;9(a) or 9(b) is unavailable to an indemnified party or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each indemnifying party under such paragraph, in lieu of indemnifying such
indemnified party thereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received
by the indemnifying party or parties on the one hand and the indemnified party or parties on the other hand from the offering of the Securities or (ii)&nbsp;if the allocation provided by clause&nbsp;9(d)(i) above is not permitted by applicable law
in such proportion as is appropriate to reflect not only the relative benefits referred to in clause&nbsp;9(d)(i) above but also the relative fault of the indemnifying party or parties on the one hand and of the indemnified party or parties on the
other hand in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the
Underwriters on the other hand in connection with the offering of the Securities shall be deemed to be in the same respective proportions as the net proceeds after commissions but before other offering expenses received by the Company from the
offering of the Securities and the total underwriting discounts and commissions received by the Underwriters in respect thereof. The relative fault of the Company on the one hand and the Underwriters on the other hand shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters and the
parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Underwriters&#146; respective obligations to contribute pursuant to this Section&nbsp;9 are several in proportion
to the respective principal amount of Securities they have purchased hereunder, and not joint. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Company and the Underwriters agree
that it would not be just or equitable if contribution pursuant to this Section&nbsp;9 were determined by <I>pro rata</I> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that
does not take account of the equitable considerations referred to in Section&nbsp;9(c). The amount paid or payable by an indemnified party as a result of the losses, claims, damages and liabilities referred to in Section&nbsp;9(c) shall be deemed to
include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this
Section&nbsp;9, no </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the Securities underwritten by it and distributed to the public were offered to
the public exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the
meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The remedies provided for in this Section&nbsp;9 are not exclusive and shall not limit
any rights or remedies which may otherwise be available to any indemnified party at law or in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The indemnity and contribution
provisions contained in this Section&nbsp;9 and the representations, warranties and other statements of the Company contained in this Agreement shall remain operative and in full force and effect regardless of (i)&nbsp;any termination of this
Agreement, (ii)&nbsp;any investigation made by or on behalf of any Underwriter, any person controlling any Underwriter or any affiliate of any Underwriter, or the Company, its officers or directors or any person controlling the Company and
(iii)&nbsp;acceptance of and payment for any of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.</B> <I>Termination</I>. The Underwriters may terminate this
Agreement by notice given by you to the Company, if after the execution and delivery of this Agreement and prior to the Closing Date (i)&nbsp;trading generally shall have been suspended or materially limited on, or by, as the case may be, any of the
New York Stock Exchange or the NASDAQ Global Market, (ii)&nbsp;trading of any securities of the Company shall have been suspended on any national securities exchange, (iii)&nbsp;a material disruption in securities settlement, payment or clearance
services shall have occurred, (iv)&nbsp;any moratorium on commercial banking activities shall have been declared by Federal or New York State authorities or (v)&nbsp;there shall have occurred any outbreak or escalation of hostilities, or any change
in financial markets or any calamity or crisis that, in your judgment, is material and adverse and which, individually or together with any other event specified in this clause&nbsp;(v), makes it, in your judgment (after consultation with the
Company, if practicable), impracticable or inadvisable to proceed with the offer, sale or delivery of the Securities on the terms and in the manner contemplated in the Time of Sale Prospectus or the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.</B> <I>Effectiveness; Defaulting Underwriters</I>. This Agreement shall become effective upon the execution and delivery hereof by the
parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, on the Closing Date, any one or more of the Underwriters shall fail or refuse to purchase Securities that it has or
they have agreed to purchase hereunder on such date, and the aggregate principal amount of Securities which such defaulting Underwriter or Underwriters agreed but failed or refused to purchase is not more than
<FONT STYLE="white-space:nowrap">one-tenth</FONT> of the aggregate principal amount of the Securities to be purchased on such date, the other Underwriters shall be obligated severally in the proportions that the principal amount of Securities set
forth opposite their respective names in Schedule&nbsp;I bears to the aggregate principal amount of Securities set forth opposite the names of all such <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters, or in such other proportions
as you may specify, to purchase the Securities which such defaulting Underwriter or Underwriters agreed but failed or refused to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchase on such date; <I>provided</I> that in no event shall the principal amount of Securities that any Underwriter has agreed to purchase pursuant to this Agreement be increased pursuant to
this Section&nbsp;11 by an amount in excess of <FONT STYLE="white-space:nowrap">one-ninth</FONT> of such principal amount of Securities without the written consent of such Underwriter. If, on the Closing Date, any Underwriter or Underwriters shall
fail or refuse to purchase the Securities and the principal amount of Securities with respect to which such default occurs is more than <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the aggregate principal amount of Securities to be purchased
on such date, and arrangements satisfactory to you and the Company for the purchase of such Securities are not made within 36 hours after such default, this Agreement shall terminate without liability on the part of any <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter or the Company. In any such case either you or the Company shall have the right to postpone the Closing Date, but in no event for longer than seven days, in order that the required
changes, if any, in the Registration Statement, in the Time of Sale Prospectus, in the Prospectus or in any other documents or arrangements may be effected. Any action taken under this paragraph shall not relieve any defaulting Underwriter from
liability in respect of any default of such Underwriter under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Agreement shall be terminated by the Underwriters,
or any of them, because of any failure or refusal on the part of the Company to comply with the terms or to fulfill any of the conditions of this Agreement, or if for any reason the Company shall be unable to perform its obligations under this
Agreement, the Company will reimburse the Underwriters or such Underwriters as have so terminated this Agreement with respect to themselves for all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
expenses (including the fees and disbursements of their counsel) reasonably incurred by such Underwriters in connection with this Agreement or the offering contemplated hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.</B> <I>Entire Agreement</I>. (a)&nbsp;This Agreement, together with any contemporaneous written agreements and any prior written
agreements (to the extent not superseded by this Agreement) that relate to the offering of the Securities, represents the entire agreement between the Company, on the one hand, and the Underwriters, on the other, with respect to the preparation of
any preliminary prospectus, the Time of Sale Prospectus, the Prospectus, the conduct of the offering, and the purchase and sale of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Company acknowledges that in connection with the offering of the Securities: (i)&nbsp;the Underwriters have acted at arm&#146;s
length, are not agents of, and owe no fiduciary duties to, the Company or any other person, (ii)&nbsp;the Underwriters owe the Company only those duties and obligations set forth in this Agreement and prior written agreements (to the extent not
superseded by this Agreement), if any, and (iii)&nbsp;the Underwriters may have interests that differ from those of the Company. The Company waives to the full extent permitted by applicable law any claims it may have against the Underwriters
arising from an alleged breach of fiduciary duty in connection with the offering of the Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) None of the Underwriters are advising the Company or any other person as to any legal,
tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions
contemplated hereby, and no Underwriter shall have any responsibility or liability to the Company with respect thereto. Any review by the Underwriters of the Company of the transactions contemplated hereby or other matters relating to such
transactions will be performed solely for the benefit of the Underwriters and shall not be on behalf of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.</B>
<I>Counterparts</I>. This Agreement may be signed in two or more counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. The words &#147;execution,&#148;
&#147;signed,&#148; &#147;signature,&#148; &#147;delivery,&#148; and words of like import in or relating to this Agreement or any document to be signed in connection with this Agreement shall be deemed to include electronic signatures, deliveries or
the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be,
and the parties hereto consent to conduct the transactions contemplated hereunder by electronic means. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.</B> <I>Applicable Law</I>.
This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and construed in accordance with the internal laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.</B> <I>Submission</I><I> to Jurisdiction; Appointment of Agents for Service</I>. Each of the parties hereto irrevocably submits to the
exclusive jurisdiction of any New York State or United States Federal court sitting in The City of New York over any suit, action or proceeding arising out of or relating to this Agreement, the Prospectus, the Registration Statement or the offering
of the Securities (each, a &#147;<B>Related Proceeding</B>&#148;). Each of the parties hereto irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying of venue of any Related
Proceeding brought in such a court and any claim that any such Related Proceeding brought in such a court has been brought in an inconvenient forum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>16.</B> <I>Waiver of Jury Trial</I>. Each of the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising
out of or relating to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.</B> <I>Headings</I>. The headings of the sections of this Agreement have been inserted for
convenience of reference only and shall not be deemed a part of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.</B> <I>Notices. </I>All communications hereunder
shall be in writing and effective only upon receipt and if to the Underwriters shall be delivered, mailed or sent to you in care of: Citigroup Global Markets Inc., 388 Greenwich Street, New York, New York 10013, Attention: General Counsel; Morgan
Stanley&nbsp;&amp; Co. LLC, 1585 Broadway, New York, NY 10036, Attention: Investment Banking Division, Fax No.: (212) <FONT STYLE="white-space:nowrap">507-8999;</FONT> Truist Securities, Inc., 3333 Peachtree Road NE, 11<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> Floor, Atlanta, Georgia 30326, Attention: Investment Grade Debt Capital Markets; and Wells Fargo Securities, LLC, 550 South Tryon Street, 5th Floor, Charlotte, NC 28202, Attention: Transaction
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Management; email: tmgcapitalmarkets@wellsfargo.com; if to the Company shall be delivered, mailed or sent to Jos&eacute; Ram&oacute;n Gonz&aacute;lez, Chief Legal Officer and Secretary, 1345
Avenue of the Americas, New York, New York 10105, with a copy to John M. Schwolsky and Benjamin Nixon, Willkie Farr&nbsp;&amp; Gallagher LLP, 787 Seventh Avenue, New York, New York 10019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>19.</B> <I>Persons Entitled to Benefit of Agreement</I>. This Agreement shall inure to the benefit of and be binding upon the parties
hereto and their respective successors and the officers and directors and any controlling persons referred to herein and the affiliates of each Underwriter referred to in Section&nbsp;9 hereof. Nothing in this Agreement is intended or shall be
construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Securities from any Underwriter shall be deemed to be a successor merely by
reason of such purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>20.</B> <I>Survival.</I> The respective indemnities, rights of contribution, representations, warranties and
agreements of the Company and the Underwriters contained in this Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment
for the Securities and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company or the Underwriters or the directors, officers, controlling persons or affiliates
referred to in Section&nbsp;9 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>21.</B> <I>Compliance with the USA Patriot Act. </I>In accordance with the requirements of the
USA Patriot Act (Title III of Pub. L. <FONT STYLE="white-space:nowrap">107-56</FONT> (signed into law October&nbsp;26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including
the Company, which information may include the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>22.</B> <I>Recognition of U.S. Special Resolution Regimes. </I>(a)&nbsp;In the event that any Underwriter that is a Covered Entity becomes
subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective
under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event that any Underwriter that is a Covered Entity and it or a BHC Act Affiliate of such Underwriter becomes subject to a
proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S.
Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used in this Section&nbsp;22: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>BHC Act Affiliate</B>&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance
with, 12 U.S.C. &#167; 1841(k). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Covered Entity</B>&#148; means any of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(i) a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(iii) a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Default Right</B>&#148; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167;
252.81, 47.2 or 382.1, as applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>U.S. Special Resolution Regime</B>&#148; means each of (i)&nbsp;the Federal Deposit
Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page Follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">EQUITABLE HOLDINGS, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Peter Tian</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Peter Tian</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: Treasurer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to the
Underwriting Agreement</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Accepted as of the date hereof</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">CITIGROUP GLOBAL MARKETS INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam D. Bordner</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Adam D. Bordner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">Title:&#8194;&#8201;&#8202;Managing Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">MORGAN STANLEY&nbsp;&amp; CO. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Courtney McCauley</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Courtney McCauley</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">Title:&#8194;&#8201;&#8202;Vice President</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">TRUIST SECURITIES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert Nordlinger</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Robert Nordlinger</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">Title:&#8194;&#8201;&#8202;Managing Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">WELLS FARGO SECURITIES, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Carolyn Hurley</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Carolyn Hurley</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">Title:&#8194;&#8201;&#8202;Managing Director</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to the
Underwriting Agreement</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE I </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount<BR>of Securities To<BR>Be Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Truist Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Time of Sale Prospectus </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Basic Prospectus dated October&nbsp;4, 2024. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Prospectus Supplement dated March&nbsp;12, 2025. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Final Term Sheet, dated March&nbsp;12, 2025, filed pursuant to Rule 433 under the Securities Act, attached as
Exhibit A to this Schedule II. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE II </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit A to Schedule II </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Filed Pursuant to Rule 433 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Registration Statement <FONT STYLE="white-space:nowrap">No.&nbsp;333-282204</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Relating to the Preliminary Prospectus Supplement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Dated March&nbsp;12, 2025 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">(To
Prospectus dated October&nbsp;4, 2024) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Equitable Holdings, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$500,000,000 6.700% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Fixed</FONT></FONT> Reset Rate Junior
Subordinated Debt Securities due 2055 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Pricing Term Sheet </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="67%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">March&nbsp;12, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Issuer:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Equitable Holdings, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trade Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">March 12, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Settlement Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">March 26, 2025 (T+10)*</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Securities:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.700% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Fixed</FONT></FONT><B> </B>Reset Rate Junior Subordinated Debt Securities due 2055 (the &#147;Securities&#148;)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Security Type:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Fixed</FONT></FONT> Reset Rate Junior Subordinated Debt Securities</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Aggregate Principal Amount:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$500,000,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Denominations:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$2,000 and integral multiples of $1,000 in excess thereof</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Maturity Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">March 28, 2055</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Initial Interest Reset Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">March&nbsp;28, 2035</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Interest Rate and Interest Payment Dates:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(i) From, and including, March 26, 2025 to, but excluding, March 28, 2035 at the rate of 6.700% per annum and (ii)&nbsp;from, and including, March 28, 2035, during each interest period, at a rate per annum equal to the five-year
Treasury rate as of the most recent reset interest determination date, in each case to be reset on each interest reset date, plus 2.390%, payable semi-annually in arrears on March 28 and September&nbsp;28 of each year, beginning on
September&nbsp;28, 2025, and on the maturity date.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Day Count Convention:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">30/360</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="67%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Offering Format:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">SEC Registered</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Public Offering Price:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">100.000% of the principal amount, plus accrued interest, if any, from March&nbsp;26, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Underwriting Discount:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">1.000%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Preliminary Prospectus Supplement:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preliminary Prospectus Supplement dated March 12, 2025, incorporating the prospectus that became effective on October&nbsp;4, 2024. If there is any discrepancy or contradiction between this Final Term Sheet and the Preliminary
Prospectus Supplement, this Final Term Sheet shall prevail.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Proceeds to Issuer (before Expenses):</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$495,000,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Optional Redemption:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Redeemable in whole at any time or in part, from time to time, (i)&nbsp;during the three-month period prior to, and including, March&nbsp;28, 2035, or the three-month period prior to, and including, each subsequent interest reset
date, at a redemption price equal to 100% of the principal amount of the Securities being redeemed and (ii)&nbsp;prior to December&nbsp;28, 2034, at a redemption price equal to the greater of (x) 100% of the principal amount of the Securities being
redeemed and (y)&nbsp;the sum of the present values of the remaining scheduled payments of principal of and interest on the Securities being redeemed discounted to the redemption date (assuming the Securities matured on December&nbsp;28, 2034) on a
semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months) at the &#147;treasury rate&#148; (as defined in the Preliminary Prospectus Supplement),
plus 40 basis points, less interest accrued to the redemption date; in each case, plus accrued and unpaid interest to but excluding the date of redemption; <I>provided</I> that if the Securities are not redeemed in whole, at least $25&nbsp;million
aggregate principal amount of the Securities, excluding any Securities held by us or any of our affiliates, must remain outstanding after giving effect to such redemption and all accrued and unpaid interest, including deferred interest, must be paid
in full on all outstanding Securities for all interest periods ending on or before the date of redemption.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Redemption on Tax Event, Rating Event or Regulatory Capital Event:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Redeemable in whole, but not in part, at any time within 90 days after the occurrence of a &#147;tax event,&#148; a &#147;rating agency event&#148; or a &#147;regulatory capital event&#148; (as defined in the Preliminary Prospectus
Supplement), at a redemption price equal to (i)&nbsp;in the case of a &#147;tax event&#148; or a &#147;regulatory capital event,&#148; 100% of their principal amount or (ii)&nbsp;in the case of a &#147;rating agency event,&#148; at a redemption
price equal to 102% of their principal amount; plus, in each case, accrued and unpaid interest to, but excluding, the date of redemption.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CUSIP / ISIN:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">29452E AD3 / US29452EAD31</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Joint Book-Runners:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morgan
Stanley&nbsp;&amp; Co. LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Truist Securities, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Wells
Fargo Securities, LLC</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pursuant to Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> of the Securities Exchange Act of 1934, as
amended, trades in the secondary market generally are required to settle in one business day unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Securities prior to the first business day
before delivery of the Securities will be required, by virtue of the fact that the Securities initially will settle in T+10, to specify an alternative settlement cycle at the time of any such trade to prevent failed settlement and should consult
their own advisors. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which
this communication relates. Before you invest, you should read the preliminary prospectus supplement and prospectus in that registration statement and other documents the Issuer has filed with the SEC for more complete information about the Issuer
and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you
request it by calling Citigroup Global Markets Inc. toll free at +1 (800) <FONT STYLE="white-space:nowrap">831-9146;</FONT> Morgan Stanley&nbsp;&amp; Co. LLC toll free at +1 (866) <FONT STYLE="white-space:nowrap">718-1649;</FONT> Truist Securities,
Inc. toll free at +1 (800) <FONT STYLE="white-space:nowrap">685-4786;</FONT> and Wells Fargo Securities, LLC toll free at +1 (800) <FONT STYLE="white-space:nowrap">645-3751.</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Any disclaimers or other notices that may appear below are not applicable to this communication and should be disregarded. Such disclaimers or other
notices were automatically generated as a result of this communication being sent via Bloomberg or another email system. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Significant Subsidiaries </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AllianceBernstein L.P. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Equitable Financial Life Insurance
Company </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Equitable Financial Life Insurance Company of America </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Equitable Network, LLC </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">III-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Annex A-I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Form of Opinion of Willkie Farr&nbsp;&amp; Gallagher LLP, Counsel to the Company</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-I-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Annex A-II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Form of Disclosure Letter of Willkie Farr&nbsp;&amp; Gallagher LLP, Counsel to the Company</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Annex B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Form of Opinion of Jos&eacute; Ram&oacute;n Gonz&aacute;lez, Chief Legal Officer and Secretary of the Company</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>axaeq-20250312.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 3/13/2025 11:58:23 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:axaeq="http://www.axa-equitable.com/20250312"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.axa-equitable.com/20250312"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" namespace="http://fasb.org/us-types/2024" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="axaeq-20250312_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="axaeq-20250312_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="axaeq-20250312_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="axaeq_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="axaeq_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>axaeq-20250312_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 3/13/2025 11:58:25 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="axaeq-20250312.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="axaeq-20250312.xsd#axaeq_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="axaeq_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="axaeq-20250312.xsd#axaeq_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="axaeq_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesCPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="axaeq_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="axaeq_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="26" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="52.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="53.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="54.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>axaeq-20250312_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 3/13/2025 11:58:23 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="axaeq-20250312.xsd#axaeq_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="axaeq_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axaeq_DocumentAndEntityInformationTable" xlink:to="axaeq_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="axaeq_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="axaeq_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="axaeq-20250312.xsd#axaeq_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="axaeq_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="axaeq_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="axaeq_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="axaeq_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series A Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesCPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series C Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C Preferred Stock [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>axaeq-20250312_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 3/13/2025 11:58:23 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="axaeq-20250312.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="axaeq-20250312.xsd#axaeq_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="axaeq_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="axaeq_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="axaeq-20250312.xsd#axaeq_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="axaeq_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationTable" xlink:to="axaeq_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesCPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="53.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="axaeq_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="54.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g937167g0313090520478.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g937167g0313090520478.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !6 'D# 2(  A$! Q$!_\0
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M*N75S%:6DUU,^V&%&D=L=% R3^5<)KG_ "6[PO\ ]@^Y_D:ZWQ/_ ,BGJ_\
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45-*S]!K='IG:EHHKG-0HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm44969012443984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axaeq_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001333986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 12,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Equitable Holdings, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">90-0226248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1345 Avenue of the Americas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(212)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">554-1234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axaeq_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EQH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axaeq_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EQH PR A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_axaeq_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series C<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EQH PR C<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_axaeq_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">axaeq_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>axaeq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ -(-M6APX9>H_ 0  / (
M  \   !X;"]W;W)K8F]O:RYX;6R-4<MNPD ,_)75?D 34(M41+B4/I"J%I6*
M^Y)UB,4^(J\#+5]?)U%4I%YZ\GILC6=F%^=(QWV,1_7E74B%KIF;>9:EL@9O
MTDUL(,BDBN0-2TN'+#4$QJ8:@+W+IGD^R[S!H)>+D6M#V743&4K&& 3L@!W"
M.?W.NU:=,.$>'?)WH?NW ZT\!O1X 5OH7*M4Q_-+)+S$P,9M2XK.%7HR#'9
MC.4?>-N)_#3[U"-L]A]&A!1ZE@MAA92XW^CYC6@\@2P/7<OQ"1T#K0S#,\6V
MP7#H:,1%=F6CSV&L0XAS^D^,L:JPA%4L6P^!AQP)7"<PI!J;I%4P'@H]KB@3
MK'H,+"&I=1BH9+=S*J?7=G#-(O<J0YJC#&AM!^&C6@L5!K!O<B )+LF5&U)=
MZ7FFMW>3>TFH=>Y!L/?P&HT=S8\?M_P!4$L#!!0    ( #2#;5HD'INBK0
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ -(-M6N1QF&7O    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M-(-M6IE<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    "  T@VU:TJ7R?T4%  !!&0  &
M    @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M-(-M6I^@&_"Q @  X@P   T              ( !B0T  'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    "  T@VU:EXJ[',     3 @  "P              @ %E
M$   7W)E;',O+G)E;'-02P$"% ,4    "  T@VU:'#AEZC\!   \ @  #P
M            @ %.$0  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ -(-M
M6B0>FZ*M    ^ $  !H              ( !NA(  'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ -(-M6F60>9(9 0  SP,  !,
M         ( !GQ,  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^
) @  Z10

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d937167d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>axaeq-20250312.xsd</File>
    <File>axaeq-20250312_def.xml</File>
    <File>axaeq-20250312_lab.xml</File>
    <File>axaeq-20250312_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="d937167d8k.htm">d937167d8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g937167g0313090520478.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d937167d8k.htm": {
   "nsprefix": "axaeq",
   "nsuri": "http://www.axa-equitable.com/20250312",
   "dts": {
    "schema": {
     "local": [
      "axaeq-20250312.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "axaeq-20250312_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "axaeq-20250312_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "axaeq-20250312_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d937167d8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 3,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 3,
   "elementCount": 30,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 28
   },
   "report": {
    "R1": {
     "role": "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-03-12_to_2025-03-12",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d937167d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-03-12_to_2025-03-12",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d937167d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "axaeq_DocumentAndEntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.axa-equitable.com/20250312",
     "localname": "DocumentAndEntityInformationLineItems",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "axaeq_DocumentAndEntityInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.axa-equitable.com/20250312",
     "localname": "DocumentAndEntityInformationTable",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesCPreferredStockMember",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Series C Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.axa-equitable.com//20250312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-25-053947-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-053947-xbrl.zip
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MI>(&^8;ZN_IRX&P33;\B5V[Y'U!+ P04    "  T@VU:U(:Q+(H%  #,.0
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MWNC,4-4U1W:550G[\>'B%5D*C'^&(X$&#UO*>T<#..I7-+J$!>I@@ [QZ&U
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MZ^(B]C_$Q%4Y^8O"7MH!:V2;[^?WCI5'<H-T2^_Z*,-=7W9/^[T[WU22\K1
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M.+%K=&M934L]TE&N<0?[O9M?0IO6#--&4\R49WCW!E.JEL.K<<BV6(INW2U
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MF!$+I1ID5/VR<'V\N2BZ_-&$'KFK<>0I.*X2_@UD;PPY><,S#9QEFO+/5CO
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M9C@7%[M1<;/@""31 \^ B&\A,69:JCA$:#XK!2&&#Q8CI#52K D%;I]DGL8
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M%>NGJ+$:S@K+4J:_N#==- -7O(P?+"L9F?BW6&+U,_0Y W:O0-E@?V=Z2 ?
MIRZZ2*5[29P5ZL;/<.8TEIZ9>%*IH9M>#?M?B0FYB'ZCBB03W($JXB6;IC=
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M;UR44=7<VV-;AJUC[ZRN>VB]8J5)-ZIM[!R+0IHM=-Q<XQ5#Z6+Z53D7NLW
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MT1>PU-=?!BM;FUNKBR,4NQO/UIZ_>/%B3X=#S_(*!(CG;I9-@?\%GU!(X'X
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M>>O$YR]8UTN U)*YTY@;\E?K]F8%T/X,_IV"CDOP2+E%Y8S$QUR;S]#0HQG
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M3M>X_'."HX+F!/!)F)1F=C@"=5QX6&51/;Z[<5G[/;=-:TM:J*8N]T$8X8[
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M>&%E<2TR,#(U,#,Q,E]D968N>&UL4$L! A0#%     @ -(-M6G= M$?9!P
M9%D  !8              ( !(0H  &%X865Q+3(P,C4P,S$R7VQA8BYX;6Q0
M2P$"% ,4    "  T@VU:U(:Q+(H%  #,.0  %@              @ $N$@
M87AA97$M,C R-3 S,3)?<')E+GAM;%!+ 0(4 Q0    ( #2#;5H'@:LLEA$
M )IY   .              "  >P7  !D.3,W,38W9#AK+FAT;5!+ 0(4 Q0
M   ( #2#;5K%:,:?I6\  $52 @ 0              "  :XI  !D.3,W,38W
M9&5X,3$N:'1M4$L! A0#%     @ -(-M6B!J5R,$#0  G0T  !D
M     ( !@9D  &<Y,S<Q-C=G,#,Q,S Y,#4R,#0W."YJ<&=02P4&      <
,!P#- 0  O*8

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d937167d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="axaeq-20250312.xsd" xlink:type="simple"/>
    <context id="duration_2025-03-12_to_2025-03-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333986</identifier>
        </entity>
        <period>
            <startDate>2025-03-12</startDate>
            <endDate>2025-03-12</endDate>
        </period>
    </context>
    <context id="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333986</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-12</startDate>
            <endDate>2025-03-12</endDate>
        </period>
    </context>
    <context id="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333986</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-12</startDate>
            <endDate>2025-03-12</endDate>
        </period>
    </context>
    <context id="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333986</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-12</startDate>
            <endDate>2025-03-12</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-271">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-03-12_to_2025-03-12"
      id="Hidden_dei_EntityCentralIndexKey">0001333986</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-306">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-307">2025-03-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-308">Equitable Holdings, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-309">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-310">001-38469</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-311">90-0226248</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-312">1345 Avenue of the Americas</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-313">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-314">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-315">10105</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-316">(212)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-317">554-1234</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-318">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-319">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-320">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-321">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-322">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-323">EQH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-324">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember"
      id="ixv-325">Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series A</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember"
      id="ixv-326">EQH PR A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember"
      id="ixv-327">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesCPreferredStockMember"
      id="ixv-328">Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series C</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesCPreferredStockMember"
      id="ixv-329">EQH PR C</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-03-12_to_2025-03-12_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesCPreferredStockMember"
      id="ixv-330">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-03-12_to_2025-03-12" id="ixv-331">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
